Cizolirtine Citrate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCizolirtine Citrate
Drug Alias Name柠檬酸西唑来汀E-4960 ((R)-isomer)E-4018E-4960E-4961 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcitonin gene-related peptide antagonists
TargetsCalcitonin gene-related peptide
Therapy Area/IndicationsPainUrinary IncontinenceUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEsteve Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEsteve Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsPainUrinary IncontinenceUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A